The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of the Tide-A study evaluating avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients with metastatic renal cell carcinoma (mRCC).
 
Daniela Arduini
No Relationships to Disclose
 
Chiara Ciccarese
Honoraria - Ipsen; MSD; Pfizer
Consulting or Advisory Role - Astellas Oncology; Ipsen; Janssen; Merck; MSD; Pfizer
Speakers' Bureau - Astellas Oncology; Ipsen; MSD; pfizer
Research Funding - AIRC
Travel, Accommodations, Expenses - Astellas Oncology; Ipsen; Merck; MSD; Pfizer
 
Alessandro Acunzo
No Relationships to Disclose
 
Matteo Perrino
No Relationships to Disclose
 
Marco Maruzzo
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Exelx; Janssen; Merck Serono; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Elena Verzoni
Consulting or Advisory Role - Janssen Oncology; MSD/AstraZeneca; Pfizer
Speakers' Bureau - AstraZeneca/Merck; Eisai Europe; Ipsen; Janssen Oncology; MSD Oncology; Novartis
 
Caterina Accettura
No Relationships to Disclose
 
Lucia Bonomi
Honoraria - AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology
Consulting or Advisory Role - Ipsen; Janssen Oncology; Roche
Travel, Accommodations, Expenses - Ipsen
 
Consuelo Buttigliero
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen-Cilag; Merck
Speakers' Bureau - Ipsen
 
Malvina Cremante
No Relationships to Disclose
 
Stefania Pipitone
No Relationships to Disclose
 
Mario Scartozzi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD; Rottapharm Biotech; SERVIER
Speakers' Bureau - Amgen; Bristol Myers Squibb Foundation; GlaxoSmithKline; Merck; MSD; SERVIER
Travel, Accommodations, Expenses - Merck; MSD; SERVIER
 
Cristina Masini
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen; MSD
Travel, Accommodations, Expenses - Ipsen
 
Veronica Mollica
No Relationships to Disclose
 
Francesca Primi
No Relationships to Disclose
 
Alessandro Strusi
No Relationships to Disclose
 
Sebastiano Buti
Consulting or Advisory Role - Astellas Pharma; BMS; Ipsen; Merck; Merck/Pfizer; MSD; Pfizer
Speakers' Bureau - Astellas Pharma; BMS; Ipsen; Merck; Merck/Pfizer; MSD; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Paolo Andrea Zucali
Honoraria - Astellas Pharma; AstraZeneca; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Ipsen; MSD; Novartis; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; MSD; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; MSD Avenir; Pfizer; Roche
 
Emanuela Fantinel
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Ipsen; Janssen; MSD
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Ipsen; Janssen; MSD
 
Roberto Iacovelli
Honoraria - Astellas Pharma; IPSEN; MSD; Pfizer
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; Bayer; Eisai; Genenta Science; Janssen; Merck; MSD; Novartis; Pfizer; Sanofi
Speakers' Bureau - Ipsen; Janssen; MSD; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; MSD; Pfizer